PathWave Psychiatry – Berkeley, California Ketamine Clinics

✓ Last verified: February 19, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: East Bay’s most insurance-friendly ketamine option, offering Spravato (esketamine) covered by major plans alongside TMS therapy. Led by board-certified psychiatrist Dr. Sahab Yaqubi in Berkeley’s Elmwood neighborhood.

💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.

HealingMaps Take: PathWave Psychiatry solves the biggest barrier to ketamine treatment in the East Bay: cost. While most ketamine clinics in the Bay Area charge $400-1,100+ per session out of pocket, PathWave focuses on Spravato — the FDA-approved esketamine nasal spray that is covered by most major insurance plans including TRICARE, Medicare, Aetna, BCBS, Cigna, and UnitedHealthcare. For patients who have tried multiple medications without relief, this is often the first time ketamine-based treatment is financially accessible. Dr. Sahab Yaqubi is a board-certified psychiatrist, which means he can manage the full medication picture alongside Spravato — adjusting antidepressants, anxiolytics, and other medications in concert with the ketamine treatment. The TMS offering provides a second evidence-based neuromodulation option for patients who may not be Spravato candidates. Located in Berkeley’s Elmwood neighborhood, the clinic serves the broader East Bay including Oakland, Emeryville, and the Contra Costa corridor.

Market Position: PathWave Psychiatry is a Spravato-certified clinic in the Berkeley metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.

PathWave Psychiatry Ketamine Cost Calculator

Ketamine Protocols Compared — What’s Offered at PathWave Psychiatry

Industry pricing reference. PathWave Psychiatry has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.

What to Expect at Your First PathWave Psychiatry Appointment

1. Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (510) 925-1230 to schedule.
2. Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the PathWave Psychiatry clinical team.
3. First treatment session — supervised Spravato (intranasal esketamine) in a private treatment room, lasting approximately 90 minutes (40-minute session + 60 minutes monitoring). Sessions are held at 2999 Regent St, Suite 512, Berkeley, CA 94705. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
4. Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your Spravato session.

What to Ask on Your PathWave Psychiatry Consult Call

• How long has the PathWave Psychiatry clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
• How long does PathWave Psychiatry’s Spravato prior authorization typically take with my specific insurance plan, and what happens if it’s denied?
• California’s psychedelic-therapy regulatory landscape is evolving — do you stay current with state Department of Public Health and Medical Board guidance on ketamine prescribing?
• What does PathWave Psychiatry recommend for patients who don’t respond to the standard 6-session acute series?

Patient Questions about PathWave Psychiatry

This 4-question summary is matched to the protocols and conditions PathWave Psychiatry treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.

Does PathWave Psychiatry offer Spravato (esketamine)?

Yes — PathWave Psychiatry offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.

Is PathWave Psychiatry suited for treatment-resistant depression?

PathWave Psychiatry treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.

Does PathWave Psychiatry treat PTSD?

Yes — PathWave Psychiatry treats PTSD. Spravato can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.

Can PathWave Psychiatry help with anxiety disorders?

Yes — PathWave Psychiatry treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.

Location